SCHEMBL5163597

SCHEMBL5163597

CCC(CC)CCCOc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-c3ccc(OCCCC(CC)CC)cc3O)n2)c(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.44
LMNA P02545 4/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
GPR35 Q9HC97 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
NPC1 O15118 2/20 0.44
HTT P42858 4/20 0.43
MAPK1 P28482 4/20 0.40
TP53 P04637 2/20 0.40
TSHR P16473 2/20 0.40
MAPK10 P53779 2/20 0.40
PTK2B Q14289 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
NPSR1 Q6W5P4 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NOD2 Q9HC29 1/20 0.40
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959013 0.92 HTT (0.43) MAPTLMNACNR1CNR2GPR35
SCHEMBL5550293 0.90 GAA (0.42) MAPTLMNACNR1CNR2GPR55
SCHEMBL3813335 0.88 NPC1 (0.50) MAPTLMNACNR1CNR2GPR35
Bemotrizinol SCHEMBL29350308 0.88 TDP1 (0.43) MAPTLMNACNR1CNR2GPR35
Bemotrizinol SCHEMBL77320 0.88 TDP1 (0.43) MAPTLMNACNR1CNR2GPR35
SCHEMBL5546836 0.88 TP53 (0.37) MAPTCNR1CNR2GPR35GPR55
SCHEMBL10195000 0.88 TDP1 (0.43) MAPTLMNACNR1CNR2GPR35
Bemotrizinol SCHEMBL29360093 0.88 TDP1 (0.43) MAPTLMNACNR1CNR2GPR35
SCHEMBL22854980 0.87 TDP1 (0.42) MAPTLMNACNR1CNR2GPR35
SCHEMBL14231297 0.85 TDP1 (0.39) MAPTLMNACNR1CNR2GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070202233-A1 Plant Cell-Derived Pectin MITSUI CHEMICALS, INC. (JP) 2007-08-30 US disclosed
EP-1333803-B1 USE OF CARBOHYDRATE FOR ENHANCING THE SKIN BARRIER FUNCTION OREAL (FR) 2007-04-25 EP disclosed
EP-1333804-B1 COMPOSITIONS COMPRISING BETA-GALACTOSIDASE, N-ACETYL-GLUCOSAMINIDASE AND N-ACETYL-GALACTOSAMINIDASE, SAID COMPOSITIONS NOT COMPRISING PROTEASE OREAL (FR) 2007-03-21 EP disclosed
US-20060165632-A1 Use of carbohydrates to improve skin barrier function SOCIETE L'OREAL S.A. (FR) 2006-07-27 US disclosed
US-20050244360-A1 Cosmetic composition for greasy skin care, containing a carboxylic fatty acid or a derivative thereof L'OREAL (FR) 2005-11-03 US disclosed
EP-1581180-A1 COSMETIC COMPOSITION FOR GREASY SKIN CARE, CONTAINING A CARBOXYLIC FATTY ACID OR A DERIVATIVE THEREOF L'OREAL (FR) 2005-10-05 EP disclosed
WO-2004069219-A1 COSMETIC COMPOSITION FOR GREASY SKIN CARE, CONTAINING A CARBOXYLIC FATTY ACID OR A DERIVATIVE THEREOF L'OREAL (FR) 2004-08-19 WO disclosed
US-20040115187-A1 Compositions comprising at least one glyconsidase, said compositions containing no proteases SOCIETE L'OREAL S.A. (FR) 2004-06-17 US disclosed
US-20040062739-A1 Use of carbohydrates to improve skin barrier function SOCIETE L'OREAL S.A. (FR) 2004-04-01 US disclosed
EP-1175888-A2 Topical compositions comprising glycosylated hydroxystilbenes and their uses L'OREAL (FR) 2002-01-30 EP disclosed